[
    {
        "utterance": "Rosa Krajmalnik-Brown: I point to people so so we have an order. I can go next but I think most of you heard from me yesterday so I'll keep it really short. Just tell you that I'm an environmental engineer by training but I have always worked with microbes and how microbes interact with each other and with their environment. And now this is a topic a very important topic for my gut microbiome research. And now I will pass it to Carolina and after you introduce yourself, please pass it to someone else so we know who's speaking if that's okay. ",
        "annotations": {
            "process management": "The speaker suggests a method to keep an order of speakers.",
            "signal expertise": "The speaker explicitly states their background and expertise in environmental engineering and microbiome research.",
            "encourage participation": "The speaker invites others to contribute by introducing themselves and passing the turn to someone else."
        }
    },
    {
        "utterance": "Carolina Tropini: So I'm at the University of British Columbia. My background is in physics, but I'm currently appointed between microbiology and biomedical engineering. And I would say the the spin that we take on the microbiota is to try to understand how the abiotic environment that is in the gut affects the microbiota and this is important because all the diseases that we know that happen in the gut affects the gut environment whether it's the temperature because you have a fever or local changes say that a tumor will have a different temperature than the rest of the environment. So we take a multi scale approach to try to understand from the single cell level to the organismal level how these physical changes affect the microbiota and therefore host health. And I'll pass it on to Dave. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states her own qualifications and background in physics, microbiology, and biomedical engineering.",
            "develop idea": "The speaker elaborates on her group's approach to studying the microbiota, including their focus on the abiotic environment in the gut and its effects on the microbiota and host health.",
            "encourage participation": "The speaker invites the next person to contribute by saying 'And I'll pass it on to Dave.'"
        }
    },
    {
        "utterance": "Dave Durgan: I'm Dave Durgan, uh Baylor College of Medicine. Um, I'm interested in cardiovascular outcomes including stroke and hypertension. And uh for the past several years we've been interested in how gut dysbiosis is linked to these cardiovascular centers. Um, primarily been looking at uh gut derived metabolites, how they affect the immune system uh and gut brain axis in terms of uh regulating some of these cardiovascular relevant regions in the brain. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their background and research experience, signaling their expertise in the area of cardiovascular outcomes and gut dysbiosis.",
            "develop idea": "The speaker is elaborating on their research interests and background, providing specific details about their work."
        }
    },
    {
        "utterance": "Dave Durgan: Um and go to Ilian. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Hi, uh I'm Julian Iliev and I'm an associate professor in Wild Cornell Medicine. Uh the lab is focused on uh immunology in general with a uh you know, with a side focus that became something very major uh fungal microbiota. And uh I'm here uh because I'm very interested in the gut brain axis where we recently found uh uh pathway that is basically regulating behavior and it's starting from the gut involves immune cells and signals directly to neurons and uh there are few very interesting ideas to pursue in that area. Otherwise the major focus is inflammatory bowel disease, allergies in human diseases and that's where a lot of concepts come from those uh from those diseases directly in the lab on the translation. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states his own expertise and qualifications, mentioning his position as an associate professor in Wild Cornell Medicine and his lab's focus areas.",
            "propose new idea": "The speaker introduces new information about a pathway that regulates behavior, starting from the gut and involving immune cells and signals to neurons, indicating a new area of research or idea."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: which pathway? Which pathway? Just out of interest. ",
        "annotations": {
            "ask question": "The speaker is requesting information about a specific pathway mentioned earlier, indicating a clear request for clarification or more information."
        }
    },
    {
        "utterance": "Iliyan Iliev: So it's uh uh it's 17. So we found this uh uh organism this community of organisms that is actually uh uh kicking off this uh uh very strong production of 17 and that affected social behavior and from there we went to neuroimmunology. I'm actually coming to Duke next week I will have a seminar there on that topic. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on their previous statement about their research findings, providing more details about the organism and its effects.",
            "signal expertise": "The speaker is explicitly stating their research focus and providing details about their study, indicating their expertise in the area."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, good. ",
        "annotations": {
            "Acknowledge contribution": "verbally recognizes another group member's input, but not agreeing or expanding",
            "Supportive response": "Expressing agreement, validation, or positive evaluation for other group members' contributions without adding new content"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Email me, email me. Okay. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Can you pass it to someone else, Ilian? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by asking Iliyan Iliev to pass the turn to someone else."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, so uh uh Pamela. ",
        "annotations": {
            "encourage participation": "The speaker is encouraging Pamela to contribute by passing the turn to her."
        }
    },
    {
        "utterance": "Pamela Chang: Hi. Um, my name is Pam Chang and I'm an assistant professor at Cornell in Ithica, New York. Um, I'm trained as a chemist and an immunologist and our lab develops uh chemical approaches to look at the metabolism of the gut microbiome. So we actually make these small molecule probes to look at enzymatic activity, um, with, you know, from the bacteria in the gut. ",
        "annotations": {
            "signal expertise": "Pamela explicitly states her own expertise and qualifications related to her work."
        }
    },
    {
        "utterance": "Pamela Chang: Uh pass it to Aida. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by passing the turn to another participant."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Uh, hi everyone. Uh, I'm Aida Ibrahimi. I am at Penn State University. Um, I am an assistant professor in electrical and biomedical engineering. So I think I'm uh kind of like the outsider here. I uh work on developing uh nanobiosensors and micro devices for um monitoring and detecting different uh targets. We have been looking at small molecules like uh neurochemicals and biogenic amines as well as uh whole cell bacteria. Um, for example, we have been looking at the the response of bacteria to antibiotic or antibiotic antibacterial susceptibility testing. Um, it's response to osmotic pressure and osmotic stress in real time using these tools, devices that we make uh and uh we have been working on combining multimodal electrochemical readout with machine learning to use this data fusion to improve the robustness and accuracy of the biosensors that we um develop. So in a nutshell. ",
        "annotations": {
            "signal expertise": "Aida explicitly states her own expertise and qualifications related to her work in electrical and biomedical engineering.",
            "identify gap": "Aida hints at potentially being an outsider in the group, implying a gap in her expertise or perspective compared to others."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Nice. ",
        "annotations": {
            "Supportive response": "The utterance 'Nice. ' expresses a positive sentiment towards the content shared by Aida, indicating agreement or approval without adding new content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Rosa, shall we go to the task to the task? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a transition to the main task."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We're missing Jao. We're missing Jao. ",
        "annotations": {
            "process management": "Rosa Krajmalnik-Brown is pointing out that Jao is missing, which relates to managing the group's composition or meeting attendance."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Sorry, sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance in a substantial way that drives discussion or process forward."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Hi everyone. Uh and uh I'm assistant professor from University of Connecticut Health Center and uh my lab folks on um intermittent fasting. So we are we are very heavy on on diet. So we focus on intermittent fasting in multiple sclerosis. Uh we are looking at the uh you know, how fasting change the multiplet in gut microbiome. Uh and uh so yeah, we are very interested in how how you know, uh through diet to control the microbiome. ",
        "annotations": {
            "signal expertise": "The speaker mentions their position as an assistant professor and describes their research focus."
        }
    },
    {
        "utterance": "Yanjiao Zhou: That's what we do. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Nice. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and positive sentiment towards Aida's introduction.",
            "acknowledge contribution": "The speaker is verbally recognizing Aida's input."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: All right, so I posted the task on the chat just to keep us, you know, in case anyone doesn't have it close. So I posted it there, but um continue Rima. I I cut you off because I wanted to make sure that. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by posting the task on the chat and ensuring everyone is aware of it.",
            "encourage participation": "The speaker is inviting Rima to proceed and share her thoughts, encouraging her participation."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I'm good, I'm good. ",
        "annotations": {
            "None": "No relevant code strongly applies, but it's a minimal acknowledgment"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: work Rosie, we enjoyed tremendously your talk yesterday powerful. right? I I just wanted to make few remarks maybe to get so our task is to look at depression anxiety that's what we are doing yes is microbiome changes could be engineered to be protective. We want to engineer that's the ultimate goal. ",
        "annotations": {
            "supportive response": "The speaker expresses a positive evaluation of Rosie's talk, indicating a supportive response.",
            "clarify goal": "The speaker clarifies the task and objectives, defining what needs to be accomplished."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: And we need a scribe. ",
        "annotations": {
            "assign task": "The speaker is assigning the role of a scribe to a group member, which involves assigning responsibility or a task."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Rosa, Rosa, okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And we need a scribe? Can we get a scribe before we start talking? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by asking for a scribe.",
            "assign task": "The speaker is assigning the task of being a scribe to someone in the group."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: We need a scribe. Yes. Yes, we need a scribe. Sorry. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by requesting a scribe to be assigned."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I'll ask you Rima. ",
        "annotations": {
            "assign task": "Rosa Krajmalnik-Brown is assigning the task of being a scribe to Rima."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: should we get one any volunteers? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by asking for volunteers for a task, which is getting a scribe.",
            "encourage participation": "The speaker is inviting others to contribute by volunteering for the task of being a scribe."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Someone who can take notes into these slides. ",
        "annotations": {
            "process management": "Rima is managing the meeting flow by ensuring someone takes notes.",
            "assign task": "Rima is assigning the task of note-taking to someone in the group."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: That's what we did yesterday it worked well. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive evaluation of a past action.",
            "process management": "The speaker is reflecting on and commenting on a process or method used the previous day."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Should we volunteer someone? ",
        "annotations": {
            "process management": "The speaker is suggesting a way to organize group activities by proposing to volunteer someone as a scribe.",
            "assign task": "The speaker is considering assigning the task of being a scribe to someone in the group."
        }
    },
    {
        "utterance": "Dave Durgan: Sure, I can do that. ",
        "annotations": {
            "assign task": "Dave Durgan volunteers to take on the task of being a scribe, thereby assigning the task to himself."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Okay, thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Can you can you go into the the link and just start uh taking notes and then what what I did yesterday Rima is I did a little bit before than 10 minutes so we could all see what is written and we can all make sure that the key points are there. ",
        "annotations": {
            "process management": "The speaker is instructing someone to take notes and share them with the group, managing the meeting flow.",
            "assign task": "The speaker assigns the task of taking notes to someone in the group."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I'll let you continue talking after we get Dave settled for for scribing. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by indicating a pause until Dave is settled for scribing.",
            "assign task": "The speaker is ensuring that scribing is covered, which involves assigning or confirming a task for Dave."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So I think if we think about you know just few remarks I think just to maybe start the the the discussion a bit right? neuropsychiatric disorders whether it's you know degenerative psychiatric right? in general the brain the brain we believe is affected the brain is placed within within a body and is influenced by the body the the brain is dependent on the body. Therefore defining the biochemical axis, the influences of the liver, the gut microbiome, the things we eat, the exposome. ",
        "annotations": {
            "clarify goal": "The speaker is defining, clarifying, or seeking clarity on objectives, outcomes, expectations, or success criteria for the group to achieve by discussing the influence of the gut microbiome on neuropsychiatric disorders."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: We talk about an interconnected highways really that influence from the diet, the the lifestyle, the exposome to the gut microbiome, the influences of the genome added to all of this gives you at the end the readout. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the concept of interconnected influences on the gut microbiome, including diet, lifestyle, exposome, and genome, to explain how they lead to a readout or outcome."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: The readout is the deck of chemicals that we call the metabolome is the readout of all of these influences combined that defines biochemical processes, signaling events and defines quite a bit of our behavior, our biochemistry and including brain brain health. I think what I see from large initiatives by NIH whether right mental health, there's quite a bit of drive to scale up data. ",
        "annotations": {
            "Develop idea": "The speaker is expanding on previous ideas discussed about the interaction between the gut microbiome, biochemical processes, and brain health.",
            "Clarify goal": "The speaker is discussing the objectives and how they relate to the biochemical processes and brain health."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: start early maybe as early as development. My own observations in scaling up data is that the metabolism data in the blood, the information about metabolites in the blood hugely inform about things that that happen in the brain from cognition to imaging to degeneration, there is a sensing mechanism that goes from the blood to the brain and it is phenomenal, more so informative maybe than CSF. It's amazing how much there is a connectivity, right, that predicts. The bacteria produces the bacteria metabolizes some of what we eat clearly and loudly completes our metabolism and we complete the metabolism of bacteria. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing concepts related to the gut-brain axis and the role of metabolism, providing examples and insights.",
            "supportive response": "The speaker provides a positive evaluation of the connectivity between blood metabolism data and brain health.",
            "clarify goal": "The speaker mentions the goal of understanding the biochemical axis influencing brain health."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So if we look at the depth of chemicals in the blood, first of all we only know know a small subset of the big metabolome, if I can measure a thousand things today in a year or two I might be able to measure 10,000, 50,000 and what we know today is that many of them are still unidentified. Yes, we know our biochemistry, we can work with a set of metabolites that fits biochemistry we know something about. We are trying to understand the synergy between bacteria and humans, co metabolism, we are trying to model it and we are trying to understand and connect the dots to the brain. I think I'm going to stop here Rosie maybe you want to give your perspective there and then we open it all yeah. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about the metabolome, its current state of understanding, and the research goals.",
            "encourage participation": "The speaker invites Rosa to provide her perspective, encouraging participation from others in the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, so I agree with everything you said, uh, but I was thinking about the very first question which was the other way around. So we we talk a lot about the gut brain connection, right? But now we have to think maybe and I want to hear from from all of you guys. ",
        "annotations": {
            "supportive response": "The speaker agrees with previous statements, showing support and validation.",
            "develop idea": "The speaker is building upon existing ideas by suggesting a different perspective.",
            "encourage participation": "The speaker invites others to contribute their thoughts and opinions."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: What do you think about the other way around? Do these conditions that we're talking about depression and anxiety and the signals that come from the brain affect the gut microbiome and how how do these changes happen? And how do we detect these changes and how do we address these changes? So, um, I have a lot to say but I'm going to try very hard to be quiet because I want to hear from all of you guys so. ",
        "annotations": {
            "ask question": "The speaker is requesting information or thoughts from other team members on the potential impact of brain signals on the gut microbiome.",
            "encourage participation": "The speaker is inviting others to contribute their thoughts and ideas."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And I know that Carolina has her hand up very patiently. ",
        "annotations": {
            "encourage participation": "Rosa Krajmalnik-Brown is inviting Carolina to contribute by mentioning that she has her hand up, encouraging her participation in the discussion."
        }
    },
    {
        "utterance": "Carolina Tropini: Thanks you know actually um exactly how you said Rosa I I I think that we're missing the other way around. Um there was this paper a couple of years ago about uh uh exercise and how it affects the microbiota through the lactate that is produced by by the muscles and that somehow to me was kind of mind blowing that actually makes it back into the gut and feeds the bacteria. ",
        "annotations": {
            "develop idea": "Carolina is expanding on Rosa's idea by providing an example from a paper, showing how the brain (through exercise) can affect the gut microbiome.",
            "supportive response": "Carolina is expressing agreement and providing a relevant example.",
            "acknowledge contribution": "Carolina is acknowledging and building upon Rosa's contribution."
        }
    },
    {
        "utterance": "Carolina Tropini: So thinking about how uh if a person is stressed if a person is producing different types of uh hormones if that makes it back into the gut that's going to be selecting bacteria that that will make different metabolites which then feeds back comes into the entire system. And um and that's just a really hard um loop to figure out and to tease apart cause and effect and but you know I feel like we've in the realm of um what's important on the humans versus microbiome we've we've now become really focused on like the microbiome impacting everything and and I really feel like we're missing a little bit the fact that there's a huge amount that we produce too that feeds back into the microbiota. Uh and um I I think I agree that this is a super important thing to think about because we produce massive amount of things that make it to the microbiome as well. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of the interaction between human factors (like stress and hormone production) and the gut microbiome, elaborating on how these factors interplay.",
            "propose new idea": "The speaker introduces the perspective that human products can affect the microbiome, highlighting the often-overlooked aspect of humans influencing the microbiota."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Good point. ",
        "annotations": {
            "acknowledge contribution": "Rima is verbally recognizing Carolina's input.",
            "supportive response": "Rima is expressing agreement and positive evaluation of Carolina's statement."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Definitely. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement, which is a positive evaluation or validation of the contribution."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Did you get that Dave? ",
        "annotations": {
            "ask question": "The speaker is requesting information or confirmation from Dave, fitting the definition of asking a question."
        }
    },
    {
        "utterance": "Dave Durgan: Yep. ",
        "annotations": {
            "None": "The utterance is a simple acknowledgment without adding new content or context to the conversation."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So go ahead Dave. ",
        "annotations": {
            "supportive response": "It's a positive and encouraging response to Dave, allowing him to proceed.",
            "encourage participation": "By saying 'go ahead,' Rima is encouraging Dave to participate and take his role as scribe."
        }
    },
    {
        "utterance": "Dave Durgan: So I would agree with. ",
        "annotations": {
            "supportive response": "Expressing agreement with a prior statement without adding new content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Dave Durgan: I was just going to just add to that. I think that the top down signaling it's always recognized that it's there but it seems much less well developed. ",
        "annotations": {
            "develop idea": "Dave is expanding on a previously mentioned idea by sharing his thoughts on top-down signaling.",
            "critical response": "Dave is providing a thought that could be seen as slightly critical or at least not fully supportive of the current understanding of top-down signaling, indicating a nuanced view."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It's that gut feeling, you know? ",
        "annotations": {
            "express humor": "The speaker makes a joke or a lighthearted comment about the 'gut feeling', attempting to humorously highlight the intuitive or unexplainable aspect of the gut-brain connection."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, good one, good one. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and positive evaluation for a previous contribution, providing a supportive response without adding new content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Right, but how do you study it? How can you study it? Really think about it, right? This by directionality which clearly must be there. There must be something going both ways. ",
        "annotations": {
            "ask question": "The speaker is requesting thoughts on how to study the bidirectional relationship between the gut microbiome and the brain, seeking methodological insights.",
            "identify gap": "By questioning how to study the bidirectional relationship, the speaker is implicitly pointing out that there is a gap in current understanding or methodology."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: How do we tease it apart? How do we study it? And if we want to end up by fixing the gut microbiome, if it is the other way, if it's coming from the brain and affecting continuously the gut microbiome, are we going to succeed, right? So what are the thoughts? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on how to study the interaction between the gut microbiome and the brain, and the implications of this interaction.",
            "encourage participation": "The speaker invites others to share their thoughts, encouraging participation in the discussion."
        }
    },
    {
        "utterance": "Yanjiao Zhou: I I oh okay go ahead sorry. ",
        "annotations": {
            "supportive response": "The speaker is showing a positive evaluation of the conversation flow by yielding the floor to others.",
            "process management": "The speaker is managing the conversation flow by indicating that others should go ahead."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, Yanjiao wanted to say something, sorry. ",
        "annotations": {
            "encourage participation": "This code applies because Rosa Krajmalnik-Brown is explicitly inviting Yanjiao to contribute to the conversation.",
            "process management": "This code applies as Rosa is managing the meeting flow by ensuring Yanjiao has a chance to speak."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I I I I'm sure I'm I'm messing up your name. So please correct me if I'm saying your name wrong uh Yanjiao. And then say Krajmalnik and then we're good. ",
        "annotations": {
            "encourage participation": "The speaker invites Yanjiao to correct her name pronunciation, encouraging Yanjiao's participation.",
            "supportive response": "The speaker shows consideration for Yanjiao by wanting to pronounce her name correctly."
        }
    },
    {
        "utterance": "Yanjiao Zhou: It's it's Yanjiao. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Yanjiao Zhou: Um you know there's there's still have been um you know the by direction uh regulation had been like a a big issue from the very beginning when we start the microbiome research, right? Because at the beginning people get excited uh you know microbiome associated every disease. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the history and issues in microbiome research, building upon existing information."
        }
    },
    {
        "utterance": "Yanjiao Zhou: And then we ask the question is the microbiome causal uh all that stuff and now we we are entering into another state. So I I guess to answer the question how the how the top down like disease affect uh microbiome, right? ",
        "annotations": {
            "ask question": "The speaker is asking a question about how disease affects the microbiome.",
            "develop idea": "The speaker is expanding on existing ideas by discussing the relationship between disease and the microbiome."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Uh shouldn't we use animal models um because the model if you if you develop this model and you say that whether it's changed the microbiome which we saw in our uh MS models. We know when we immunize the the mice and uh the the you know you got you got MS disease and then the microbiome definitely change. ",
        "annotations": {
            "code name": "ask question",
            "explanation": "The speaker asks if they should use animal models."
        }
    },
    {
        "utterance": "Yanjiao Zhou: just a very you know simple idea. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And I think it's the same with most of the mouse models that the micro is different. ",
        "annotations": {
            "develop idea": "She is expanding on a previous idea about mouse models and their microbiome.",
            "supportive response": "She is contributing to the conversation in a manner that agrees or builds upon previous statements."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Like if you take an autism mouse model, the microbiome is different, right? So. ",
        "annotations": {
            "Develop idea": "The speaker is expanding on a previous idea about mouse models and their microbiome changes, specifically mentioning autism mouse models.",
            "Supportive response": "The utterance supports the discussion by agreeing with or building upon previous statements about the relationship between microbiome changes and disease models."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah but in many ways the direction going, right? Which is which way is the signal going? But but in many situations when you look at that complex composition, it's either non causal or it has an effect that is uh you know, there are a lot of confounders. So we started actually looking at uh uh defining basically partners. ",
        "annotations": {
            "ask question": "The speaker asks a rhetorical question about the direction of the signal.",
            "critical response": "The speaker questions the causal relationship and mentions confounders.",
            "offer feedback": "The speaker suggests an approach they've taken to deal with the complexity."
        }
    },
    {
        "utterance": "Iliyan Iliev: And then uh defining actually what they're sensing and then knocking out this pathway in the bacteria and uh it can be host metabolite. So then you you if you actually find a sensor then you knock it out and we succeeded in some of those and on plate it works beautifully. In germ free mice it might work but then a lot of those became actually not very interesting because in the complex community they just are not produced enough and there is a pharmacokinetics of each metabolite that we never considered and we started actually changing groups uh in specific metabolite and we have one proof of principle where we did like huge chemical, you know, uh change of the metabolite in different parts of the groups and that changed the pharmacodynamic uh incredibly. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on their research approach and findings, building on existing knowledge.",
            "signal expertise": "The speaker is demonstrating their expertise in microbiology and biochemical pathways.",
            "identify gap": "The speaker mentions a gap in knowledge regarding pharmacokinetics of metabolites."
        }
    },
    {
        "utterance": "Iliyan Iliev: But it didn't change the lack of activity if it's in a complex community. So a lot of reductionist approaches are teaching us about the pathways but then what is really important in vivo. So uh so so that kind of leaves room for some things to be explored but others become interesting in terms of pathways. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about the limitations of reductionist approaches in understanding complex biological systems.",
            "critical response": "The speaker is providing a critique of reductionist approaches, highlighting their limitations in vivo.",
            "identify gap": "The speaker is highlighting the gap in understanding between reductionist approaches and the complexity of in vivo systems."
        }
    },
    {
        "utterance": "Iliyan Iliev: But then not really physiologically that interesting. So it's always the balance where you want to focus and I spent literally like four years on chemistry like that and you know and uh uh and there are very few hits compared to what we came up with initially. So it's kind of uh you know, the immune side has been far more productive than the other side because just there is an over over compensation or not enough of a metabolite to actually have biological function. And then if you go and try to actually affect neurons and depends where those neurons are and then you can place actually the receptors and you can go with AVVs so now there is technology really. But some of them are just not making it at all. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on his research experiences and challenges, building upon the context provided by previous discussions.",
            "offer feedback": "The speaker is sharing his insights and lessons learned from his research, providing feedback on the feasibility and challenges of certain research directions."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So Aida, you're a biosensors person. ",
        "annotations": {
            "signal expertise": "Rosa Krajmalnik-Brown explicitly states Aida's expertise in biosensors."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Can maybe some biosensors help. ",
        "annotations": {
            "ask question": "The speaker is requesting information or expertise from other team members on a prior statement or idea proposed."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Help us some of these signals or messages. ",
        "annotations": {
            "Encourage Participation": "The speaker invites others to contribute their thoughts or ideas, seeking help on understanding signals or messages."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Um so I'm I'm sorry I had to like you know uh get to my student uh there was urgent thing in the lab. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it is primarily an apology for leaving the conversation."
        }
    },
    {
        "utterance": "Aida Ebrahimi: So uh can you like briefly say what type of signals? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about the type of signals being discussed."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So we're talking about uh how do we maybe measure detect signals from the brain to the gut. ",
        "annotations": {
            "ask question": "The speaker is requesting information on how to measure or detect signals from the brain to the gut."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We've been talking about the fact that the communication goes goes from the gut to the brain. ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing what has been previously discussed about the communication between the gut and the brain."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: But what about signals from the brain to the gut that are specific to these disorders? ",
        "annotations": {
            "ask question": "Rosa Krajmalnik-Brown is requesting information or clarification on signals from the brain to the gut that are specific to certain disorders."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah you see the currently the pro ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: that um they are related to my field like biosensors, electrical or electrochemical sensors, they are like implanted devices um that you know, you can basically only look at brain so you put brain probes uh at the specific locations that you want and then you can pick up some some signals, you know? But currently there is nothing like uh that can go all the way through the whole axis uh it doesn't exist uh with GI track uh it's specifically very challenging actually. Uh brain is easiest honestly. The brain probes they have been in the field for 50 years. So it is not even a new thing at all. ",
        "annotations": {
            "develop idea": "Aida Ebrahimi is expanding on the concept of biosensors, their use in brain research, and the current limitations in applying this technology to study the gut-brain axis.",
            "signal expertise": "Aida Ebrahimi explicitly states her familiarity with the field of biosensors and their applications, indicating her expertise.",
            "identify gap": "Aida Ebrahimi points out a gap in current technology, specifically that there are no biosensors that can go all the way through the whole gut-brain axis."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Uh now people are trying to make the probes and those sensors better, like for example, rather than using uh middle like um uh probes uh that are based on carbon fiber and they are like, you know, very fragile and etcetera, like making like flexible patches uh that you can make array of them uh using novel materials and do the measurement uh with brain and even like, you know, at the um wireless um circuit, so you don't have to like, you know, the the the wires they don't have to like stick out of the brain because that's currently how it is. There is always some wires like sticking out. So how you can implant it and also have the data communication circuit combined with that sensing modality. So there are a lot of progress in that field and that's great for brain. ",
        "annotations": {
            "develop idea": "Aida is expanding on the concept of improving brain probes, discussing specific challenges and technological advancements.",
            "signal expertise": "Aida is sharing her knowledge about biosensors and their development, indicating her expertise in the field."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, important Aida. ",
        "annotations": {
            "acknowledge contribution": "Rima verbally recognizes Aida's input.",
            "supportive response": "Rima expresses a positive evaluation of Aida's contribution by calling it 'important'."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Sorry, go ahead. Go ahead, continue. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: But with GI track um it hasn't been because of the, you know, it's very complex. There are some works that they have shown that okay, let's make capsules, like a smart capsules, a smart pills that you eat and uh, you know, there are ideas actually, like calls by NIH I remember it had started like last year. Uh it has been, you know, this idea has been around actually for a long time. I remember I was a student and this smart pill thing was mentioned multiple times, but I haven't seen any really advancement and real thing rather than some passive components that they can go through and sample, sample like for example, go to intestine and sample bacteria, then the human or the subject um excrete that and then they collect the sample and do the traditional analysis, you know? But something that for example, can do all this screening, even simplest electrical screening and give the signal out because you see in our body we cannot stick wires out. That's the thing. With brain, that's as at least like to some extent you say it's here, it doesn't move, that's another big problem. It doesn't move, it is fixed. So even if there are some wires coming out, that's still okay. But how are you going to do that with, you know, with the like our stomach or our intestine, you know? Where are the wires are going to come out? ",
        "annotations": {
            "propose new idea": "Aida discusses the idea of making smart capsules or pills for screening in the GI tract.",
            "develop idea": "Aida elaborates on the challenges and existing works related to developing such technology for the GI tract.",
            "signal expertise": "Aida mentions her familiarity with the field of biosensors and the challenges of working with the GI tract."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Where are they going to go? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the placement of wires or devices in the context of measuring signals from the brain to the gut."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: But Aida from from an engineering point of view, uh out of if we put a list of all metabolites that we know are gut bacteria human co metabolism influence. We can put a list. We are after it and it's going to expand. You know, it's expanding by the day. But if we say neurotransmitters from the GABA, and serotonin, glutamate, norepinephrin, out of all of these, what what do we have? We know we can do a FMR. ",
        "annotations": {
            "ask question": "The speaker is requesting information about the current state of knowledge or methods for measuring specific neurotransmitters influenced by gut bacteria and human co-metabolism."
        }
    },
    {
        "utterance": "Aida Ebrahimi: For all of them like GABA and you know, the catacolamines, glutamate, for all of them sensors uh exist, electrochemical sensors. ",
        "annotations": {
            "signal expertise": "Aida Ebrahimi explicitly states her knowledge about the existence of electrochemical sensors for certain neurotransmitters, demonstrating her expertise in the field of biosensors."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Electrochemistry, yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yes. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Electrochemistry based. ",
        "annotations": {
            "supportive response": "The speaker is acknowledging and supporting the mention of electrochemistry as a method, indicating agreement or confirmation of its relevance to the discussion."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yes. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Electrochemical sensors they exist. ",
        "annotations": {
            "supportive response": "The speaker provides a positive validation of the existence of electrochemical sensors, directly answering the query."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Um now for an those probes that I mentioned for brain, they actually can do this. Uh they can achieve this detection. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the capabilities of probes previously mentioned, providing more information on what they can achieve.",
            "supportive response": "The speaker is providing a positive affirmation that these probes can indeed achieve the detection mentioned."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Uh now if we want to, so, you know, my point was, let's say someone's someone says, like for example myself, I'm very interested in saliva monitoring, sweat monitoring, uh non-invasive monitoring. So I always have asked like, you know, experts such as yours, such as you, um like are they like the signatures um that I can just look at saliva for those biomarkers and correlate that to Parkinson disease or Alzheimer or things like that. ",
        "annotations": {
            "ask question": "Aida Ebrahimi is seeking information from experts on whether there are signatures or biomarkers in saliva or sweat that can be correlated with Parkinson's disease or Alzheimer's disease."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Because saliva or sweat, they are really non-invasive and you know, it's easier uh to make sensors for them from my perspective. ",
        "annotations": {
            "signal expertise": "The speaker is sharing her perspective on the ease of developing sensors for saliva or sweat, indicating her expertise in the field of biosensors."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: That's great. ",
        "annotations": {
            "supportive response": "The utterance expresses a positive evaluation, agreeing with a previous statement."
        }
    },
    {
        "utterance": "Aida Ebrahimi: But you see the concentrations are so tiny. ",
        "annotations": {
            "identify gap": "Aida is highlighting a challenge in detecting biomarkers due to their tiny concentrations, implying a gap in current technology or methods.",
            "offer feedback": "Aida is providing a perspective on the challenges of biomarker detection, which can be seen as feedback on the feasibility of certain approaches."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Brain for all. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah, yeah. So exactly. ",
        "annotations": {
            "Supportive Response": "Expressing agreement with the previous speaker without adding new content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: For all compounds. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah, yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: So if it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I think that. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Aida you are right on. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement and validation of Aida's contribution."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: We do not need to get to the brain for everything, right? ",
        "annotations": {
            "critical response": "The speaker is mildly questioning the focus on the brain's role in certain conditions, suggesting an alternative perspective.",
            "None": "No other code seems to directly and exclusively apply to this utterance in a meaningful way."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: If we believe that neuropsychiatric disorders are systemic diseases and everything we have done over the past 20 years metabolically is telling us, look, the brain is affected, but many other organs are affected. ",
        "annotations": {
            "clarify goal": "The speaker is discussing and clarifying the perspective on neuropsychiatric disorders being systemic diseases.",
            "develop idea": "The speaker is expanding on the idea that neuropsychiatric disorders affect not just the brain but many other organs."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: And this might be a systemic disregulation metabolically, right? Across connecting the compartments, saliva, blood, urine, things we can measure easily is a is a must, is a must, really. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about the systemic nature of metabolic disregulation.",
            "supportive response": "The speaker is validating the approach of considering multiple bodily compartments.",
            "clarify goal": "The speaker is emphasizing the importance of a systemic approach, clarifying the goal."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: And I think. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: That's it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: But you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it seems incomplete and doesn't explicitly fit into any category provided."
        }
    },
    {
        "utterance": "Iliyan Iliev: Carolina has been raising her hand very patiently. ",
        "annotations": {
            "encourage participation": "Iliyan Iliev is encouraging Carolina to participate by mentioning that she has been raising her hand, indicating she wants to contribute to the discussion."
        }
    },
    {
        "utterance": "Iliyan Iliev: Oh, sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: You can also start directing. ",
        "annotations": {
            "process management": "The speaker is suggesting a change in the management of the discussion or meeting by inviting someone else to start directing."
        }
    },
    {
        "utterance": "Carolina Tropini: I mean maybe it's a little bit easier. ",
        "annotations": {
            "supportive response": "Carolina's response is a brief, agreeable comment that acknowledges the complexity of the issue."
        }
    },
    {
        "utterance": "Carolina Tropini: Um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: I guess one thing that I was going to say is that. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: I think we also need to think about sensors that are more localized instead of just like saying like taking from the saliva or from the stool. ",
        "annotations": {
            "propose new idea": "The speaker suggests developing sensors that are more localized.",
            "develop idea": "The speaker builds upon the existing discussion on sensor development by suggesting a more targeted approach.",
            "offer feedback": "The speaker provides specific feedback on current approaches, suggesting they are not optimal."
        }
    },
    {
        "utterance": "Carolina Tropini: Because at least for the microbiota the concentrations can be really, really high but locally. So if you if you measure them out of the entire stool and the entire saliva, you might see that they're very low levels, but in practice they're they can if they're locally at a really high level, they can have physiological effects that are really high. ",
        "annotations": {
            "develop idea": "Carolina is expanding on the idea that local concentrations of microbiota can have significant physiological effects, even if the overall concentrations in stool or saliva seem low.",
            "offer feedback": "She is also providing feedback on how to interpret the data from measurements, emphasizing the importance of local concentration levels."
        }
    },
    {
        "utterance": "Carolina Tropini: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Should we move to the next question because we have a limited amount of time? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting they move to the next question due to limited time."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: This is a great discussion, but maybe we should move to the next question or the next questions. So I just put it in the chat, which is is it possible that the that microbiome changes could be engineered to be protective against negative impact of mental health disorders. ",
        "annotations": {
            "process management": "The speaker manages the discussion flow by suggesting a move to the next question.",
            "ask question": "The speaker poses a new question about the possibility of engineering microbiome changes for protection against mental health disorders.",
            "clarify goal": "The speaker aims to direct the discussion towards understanding if microbiome changes can be engineered for protective effects against mental health disorders."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I I can start on that maybe. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a minimal statement offering to start a discussion without adding substantial content."
        }
    },
    {
        "utterance": "Iliyan Iliev: Uh. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Uh so so I've been looking a lot into it and then we designed our own studies based on that. So the short question uh answer is yes, you can do that in mice. ",
        "annotations": {
            "propose new idea": "No, this code does not apply as Iliyan Iliev is not introducing a new idea.",
            "develop idea": "No, this code does not apply as Iliyan Iliev is providing a direct answer rather than elaborating on an idea.",
            "ask question": "No, this code does not apply as Iliyan Iliev is providing an answer, not asking a question.",
            "signal expertise": "No, this is not a clear example of signaling expertise.",
            "identify gap": "No, this code does not apply.",
            "acknowledge contribution": "No, this code does not apply.",
            "supportive response": "No, this code does not apply.",
            "critical response": "No, this code does not apply.",
            "offer feedback": "Yes, Iliyan Iliev offers a specific answer based on their research which can be seen as offering feedback.",
            "summarize conversation": "No, this code does not apply.",
            "express humor": "No, this code does not apply.",
            "encourage participation": "No, this code does not apply.",
            "process management": "No, this code does not apply.",
            "assign task": "No, this code does not apply.",
            "clarify goal": "No, this code does not apply.",
            "confirm decision": {
                "code": "confirm decision",
                "explanation": "Iliyan Iliev explicitly commits to an answer based on their studies, confirming that microbiome changes can be engineered in mice to be protective."
            }
        }
    },
    {
        "utterance": "Iliyan Iliev: Uh and uh it works for certain types of behaviors and uh we have done it with fungal community but there are a lot a lot of studies done it with bacterial communities with specific metabolites, but the problem is when you move to people because uh because actually the the way and the timing of uh behavior that is learned and then can lead to actually a depressive disorder or something like that. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on previous research findings, discussing the effectiveness of manipulating microbial communities to influence behavior.",
            "identify gap": "The speaker identifies a gap in knowledge, specifically the challenge of translating findings from animal studies to humans."
        }
    },
    {
        "utterance": "Iliyan Iliev: And then there there there is also a component that is uh you know, because of genetics. ",
        "annotations": {
            "identify gap": "The speaker mentions genetics as a component that needs consideration, implicitly identifying a gap in understanding the relationship between the microbiome and mental health disorders.",
            "develop idea": "The speaker is expanding on previous discussions by adding the factor of genetics."
        }
    },
    {
        "utterance": "Iliyan Iliev: But Carolina has been raising her hand very patiently. ",
        "annotations": {
            "encourage participation": "The speaker invites Carolina to contribute to the discussion by pointing out that she has been raising her hand.",
            "acknowledge contribution": "The speaker also acknowledges Carolina's potential contribution by mentioning her raised hand."
        }
    },
    {
        "utterance": "Carolina Tropini: Oh, sorry. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges Iliyan Iliev's observation about her raising her hand, showing awareness and politeness."
        }
    },
    {
        "utterance": "Carolina Tropini: You can also start directing. ",
        "annotations": {
            "encourage participation": "Carolina is encouraging Iliyan to start directing or contributing to the discussion."
        }
    },
    {
        "utterance": "Carolina Tropini: I mean maybe it's a little bit easier. ",
        "annotations": {
            "supportive response": "The speaker is showing agreement or understanding, providing a minimal response that acknowledges the previous discussion."
        }
    },
    {
        "utterance": "Carolina Tropini: Um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: I guess one thing that I was going to say is that I think we also need to think about sensors that are more localized instead of just like saying like taking from the saliva or from the stool because at least for the microbiota the concentrations can be really, really high but locally. So if you if you measure them out of the entire stool and the entire saliva, you might see that they're very low levels, but in practice they're they can if they're locally at a really high level, they can have physiological effects that are really high. ",
        "annotations": {
            "propose new idea": "The speaker introduces the idea of using more localized sensors for measuring microbiota concentrations, which is a new suggestion for approaching the problem.",
            "develop idea": "The speaker builds upon the existing discussion on measuring microbiota concentrations by suggesting a more specific and localized method, thereby developing the existing idea further."
        }
    },
    {
        "utterance": "Carolina Tropini: Yeah. ",
        "annotations": {
            "supportive response": "The utterance 'Yeah.' by Carolina Tropini is a supportive response as it acknowledges and agrees with a previous statement without adding new content."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Should we move to the next question? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a transition to the next question."
        }
    },
    {
        "utterance": "Iliyan Iliev: It's very confounding though. ",
        "annotations": {
            "critical response": "Iliyan Iliev expresses a critical response by pointing out that the topic is very confounding, indicating a challenge or negative evaluation of the complexity of the discussion."
        }
    },
    {
        "utterance": "Iliyan Iliev: That that's the problem, right? ",
        "annotations": {
            "critical response": "The speaker is highlighting a problem or challenge in the current approach or understanding, acknowledging the difficulty in studying the interaction between the microbiome and mental health disorders.",
            "ask question": "The speaker ends with 'right?', which is a rhetorical question seeking agreement or acknowledgment of the problem."
        }
    },
    {
        "utterance": "Iliyan Iliev: you know or make drugs that are hitting that pathways where the key should be I think in that direction. ",
        "annotations": {
            "develop idea": "The speaker is building upon previously discussed ideas by suggesting a concrete approach.",
            "propose new idea": "The speaker is suggesting a new approach by proposing to make drugs that target specific pathways."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I want to give one example, are you familiar with the work of Michael Fishback at Stanford? Yeah. Yeah, nice beautiful work. So I give you one example, right? We see that the indoors, let's stay with the indoors, call the bile acid, the indoors, sulfate is produced by gut bacteria out of metabolism, yes, and you can have an over producer or an under producer of sulfate. We know now high levels is no good. We know it's in the brain. We know there is no synthetic route for it in the brain. ",
        "annotations": {
            "develop idea": "The speaker provides a detailed example of sulfate production by gut bacteria and its implications.",
            "ask question": "The speaker asks if others are familiar with Michael Fishback's work."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Nothing that we can pick in as you know and so on. It must be coming most likely from from the gut. the the gut might have changed either because the brain send the signal or the diet send the signal, something changed, yeah? End result the gut microbiome changed, I am an over producer of this compound that is not good for anxiety. Yes? Okay, so can I change all together the gut microbiome composition genetically, chemically is part of what Michael Fishback does. So he can engineer now a whole area of a new gut microbiome knocking down specific enzymes that produce sulfate. ",
        "annotations": {
            "clarify goal": "The speaker clarifies the goal of changing the gut microbiome composition to impact mental health disorders like anxiety."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, because we modulate completely. That's what we do as well and the behavior changes but in humans I mean my colleague here comes from that lab and I'm very very well yeah. ",
        "annotations": {
            "signal expertise": "The speaker mentions connection to a lab and a colleague, indicating expertise.",
            "develop idea": "The speaker is discussing their work in relation to the topic."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: of course. ",
        "annotations": {
            "acknowledge contribution": "The utterance acknowledges previous information.",
            "supportive response": "The utterance indicates agreement or confirmation."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: But how do you take that to humans, Rima, which is that's the way forward. ",
        "annotations": {
            "code name": "ask question",
            "explanation": "The speaker is requesting information or clarification on how to apply a concept or finding to humans."
        }
    },
    {
        "utterance": "Iliyan Iliev: That's the way forward. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a previous statement, indicating a positive evaluation of the discussed approach."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Are we talking about fecal transplant of specific engineered types of gut microbiomes, right? And what what do we need to get there? Is it yeah, are we there? Maybe not. Maybe not yet. Yes? Maybe not yet. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on whether they are discussing fecal transplant of specific engineered types of gut microbiomes and what is required to achieve this."
        }
    },
    {
        "utterance": "Iliyan Iliev: Well but the studies on the fecal transplant, do you like them? I you know, we we do fecal transplant in IBD and I I had to read all the studies on others, the weakest one are in autism. No question. ",
        "annotations": {
            "critical response": "Iliyan Iliev is evaluating and criticizing the studies on fecal transplant, specifically comparing their quality across different conditions.",
            "ask question": "Iliyan Iliev asks for an opinion on the studies with 'do you like them?'"
        }
    },
    {
        "utterance": "Iliyan Iliev: The weakest the the weakest FMT if you go to the to to read basically how the study was designed and how the conclusions came, you know, the strongest one are in Cdiff of course, in IBD they are good. then you go to cancer therapy they are good. You go to autism and any other things. ",
        "annotations": {
            "critical response": "The speaker is providing a negative evaluation of FMT effectiveness in certain conditions (autism and others) compared to others (Cdiff, IBD, cancer therapy).",
            "offer feedback": "The speaker is offering a comparison that serves as feedback on the state of research or treatment efficacy for FMT across different medical conditions."
        }
    },
    {
        "utterance": "Iliyan Iliev: And just read the clinical design and outcome and how can you you know like I I read the studies I'm not convinced of the effect. ",
        "annotations": {
            "Critical Response": "The speaker is expressing skepticism about the effect based on their reading of clinical studies."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Rose you might disagree. Listen. ",
        "annotations": {
            "encourage participation": "The speaker addresses Rose directly and invites a response by suggesting Rose might have a differing opinion, thus encouraging participation."
        }
    },
    {
        "utterance": "Iliyan Iliev: I don't know. I mean I mean I agree. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement with a previous statement."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I I agree that we need um a a blinded, you know, like a placebo control trial. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and positive evaluation of a previous suggestion about needing a blinded or placebo control trial."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. If we agree with that, which you know, or study got reviewed in nature but it didn't get it didn't get um published in nature because the reviewers their main concern was that we didn't have a blinded placebo arm. ",
        "annotations": {
            "clarify goal": "Rosa is discussing the necessity of a blinded placebo arm in study design for publication in high-impact journals like Nature, which relates to defining and clarifying objectives for study design."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: But we saw the effects. We totally saw the effects and as we're thinking about the the gut brain and the brain gut communication, I'm thinking maybe these kids once you they didn't have these GI symptoms, they were calmer and that created some different health also the brain to the gut because the gut microbiome changed, changed dramatically after the after the treatment. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of gut-brain communication and its implications.",
            "supportive response": "The speaker is expressing agreement with previous statements and building upon them.",
            "summarize conversation": "The utterance summarizes a part of the discussion."
        }
    },
    {
        "utterance": "Iliyan Iliev: So so that's where probably the that's the area where you know like if clinical studies designed the way the Cdiff study was designed, that's where that can improve a lot. So it's not a critique but it's like actually where things can improve improve, right? In in that kind of uh studies where actually it will become a standard uh as the Cdiff, right? We are learning in IBD a lot from that. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on previous discussions about clinical study design and suggesting improvements.",
            "offer feedback": "The speaker provides specific feedback on how clinical studies can be improved by referencing the Cdiff study design.",
            "signal expertise": "The speaker demonstrates knowledge of specific studies (Cdiff, IBD) and their designs."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It's very different by the way because with Cdiff you do one inoculation and it's with one inoculation and in autism it doesn't work that way. You have to do. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by comparing the application of fecal microbiota transplantation in Cdiff and autism, highlighting the complexity of treating neurological conditions.",
            "clarify goal": "The speaker is also clarifying the goal or approach in using FMT for different conditions, emphasizing the differences in treatment application."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: get better over time and NIH is hosting a workshop on precision probiotics prebiotics they are hosting a big debate. Yes? I mean similar to how we are personalizing medicine, we want to be able to personalize right probiotics prebiotic one. So I think it's it's a matter of time but we will get better. We should not give up. Yes? We know the results are not giving up for sure. ",
        "annotations": {
            "develop idea": "The speaker elaborates on the concept of personalizing probiotics and prebiotics by comparing it to personalized medicine.",
            "supportive response": "The speaker encourages not giving up and expresses optimism about future improvements.",
            "process management": "The speaker mentions NIH hosting a workshop, indicating ongoing activity in the field."
        }
    },
    {
        "utterance": "Yanjiao Zhou: especially for this group of people. Um but you know the other question I'm always ask myself it's you know we are all microbiome person you know we we we definitely do this research but really I think the key question is to what extent the microbiome is important to the disease. Because the disease is just so complicated and microbiome may play a role but if if the role it's it's you know big enough to have impact. ",
        "annotations": {
            "identify gap": "The speaker recognizes the complexity of the disease and questions the extent of the microbiome's role, indicating a gap in current understanding.",
            "ask question": "The speaker is explicitly asking about the extent of the microbiome's importance in the disease."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, the the fecal transplant studies they are probably the key but uh how to design them and especially early life. So Rosie like the that that's where the opportunity is but uh you know how to design them in a way to really uh have a big study when you have to and and like kids it's even better, right? Because it's actually not uh is the most challenging group to design a clinical trial. That's why they are less developed but uh that's probably where we can learn a lot. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the concept of fecal transplant studies and their design, particularly in early life.",
            "ask question": "The speaker is posing questions about how to design fecal transplant studies effectively.",
            "identify gap": "The speaker highlights the challenge of designing clinical trials, especially with children, as an area where there is a need for improvement."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I do have to say it's quite challenging. You know, there are like the presentation that I gave yesterday is 10 years of research and it is really, really quite, you know, challenging. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: At one of my um iterations where we were trying to design something that I think would have been amazing if we had done it, uh but it's obviously challenging too. I had a conversation with Emeran Mayer. You probably have known Emeran um about uh scanning the brains of these children before and after the FMT. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it primarily reflects on past attempts and personal communications rather than engaging in the specific discussion activities outlined in the codebook."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: We actually submitted a proposal together, but of course the logistics would have been crazy. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Especially because we're not even in the same state, but I I think that would be amazing if we. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Amazing, amazing. Rose Rosie and a great guy, Emeran, what a great guy. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: An amazing study, it should be funded. I. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement and support for a study, indicating a positive evaluation of the idea.",
            "None": "No other relevant code applies to this utterance as it primarily functions as a supportive comment."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, that's that's another story, right? ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Another story. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's another story, but um my point is that we've been thinking about it and we've been thinking about how to be more systematic, more mechanistic and how can we learn more from what we're doing. ",
        "annotations": {
            "ask question": "The speaker asks a question about how to learn more from their work.",
            "identify gap": "The speaker identifies a gap in their approach by mentioning the need to be more systematic and mechanistic.",
            "clarify goal": "The utterance implies a reflection on research goals and approaches."
        }
    },
    {
        "utterance": "Iliyan Iliev: But but now with the first trial that uh it was probably the most challenging thing to do. The second probably people will be more open. ",
        "annotations": {
            "process management": "The speaker is discussing the management of trials, specifically the challenges faced during the first trial.",
            "develop idea": "The speaker is developing an idea about how the challenges of trials change over time, suggesting that subsequent trials will be less challenging."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: The second happened during COVID, so that was a bigger challenge, you know. ",
        "annotations": {
            "process management": "The speaker is discussing the challenges of conducting studies or trials during the COVID-19 pandemic, which directly relates to managing the process of research."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Maybe the next one, but you know. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it is a brief, ambiguous statement that does not clearly contribute to the discussion in a defined way."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: So also what I'm hearing in terms of examples of probiotics or FMT are more GI related outcomes. Um since we're kind of talking about mental health is are there really many clinical readouts um in terms of effects on brain with probiotics or with FMT. ",
        "annotations": {
            "ask question": "The speaker is requesting information about the existence of clinical readouts related to the effects on the brain with probiotics or with FMT, indicating a need for clarification or information."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So Emeran Mayer actually uh published many years ago, I'm going to say maybe 10 years ago a study with a probiotic where he showed less anxiety in females that actually took the probiotic and he showed that certain regions in the brain were lighting up differently on on the woman that took the probiotic. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by referencing a specific study.",
            "supportive response": "The speaker is providing a positive example that supports the discussion."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Important. And can Rosie can can changes in the gut in the in in in the gut reflect and end up being part of the end points in in in in psychiatric neuropsychiatric. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on whether changes in the gut can reflect and be part of endpoints in psychiatric or neuropsychiatric conditions.",
            "clarify goal": "The speaker seeks to understand the relationship between gut changes and psychiatric conditions, which involves clarifying goals or objectives of studying this relationship."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I don't I don't think we're there, but I've been thinking a lot about this Rima. This is a great question. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: In whom? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification regarding a specific group or individual related to the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So the gut microbiome might be a sensor, might be a signal, might be something that we could be measuring and using as a biomarker of something else. And it might not this doesn't mean that it's causative. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by considering the potential roles of the gut microbiome.",
            "clarify goal": "The speaker is discussing and clarifying the objectives or goals related to understanding the gut microbiome's role."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It just means that something else is changing that is giving you a signal on the gut microbiome. ",
        "annotations": {
            "develop idea": "The utterance expands on the idea that the gut microbiome could serve as a biomarker for mental health disorders, building upon previous conversations.",
            "clarify goal": "The statement helps clarify the goal of understanding the gut microbiome's role in mental health by highlighting the complexity of interpreting its changes."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Exactly, exactly. ",
        "annotations": {
            "acknowledge contribution": "The speaker is acknowledging a prior statement, showing agreement.",
            "supportive response": "The speaker is expressing agreement and validation for the prior statement."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Rosa, I have a question for you uh for your clinical study. Under the donor samples, where did you get the donor? Are the cases received the same donor or different donors? ",
        "annotations": {
            "ask question": "Yanjiao Zhou is requesting information about the donor samples used in Rosa's clinical study, specifically where the donors were sourced and whether cases received the same or different donors."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That is that is a great question and I probably went too fast yesterday and I should have mentioned that, but I had certain amount of time. So each patient actually received microbio from two different donors because the high dose was from one donor and the maintenance dose was from another donor. And we didn't want it that way when we designed it, we wanted just one donor to keep things more systematic, but I would say we got lucky because I think the fact that we added two donors increased the diversity and our maintenance donor actually happened to be a donor that had very high diversity if you looked on the graphs. ",
        "annotations": {
            "develop idea": "Rosa is providing detailed information about the study, including the use of microbiota from two different donors and the outcome of increased diversity.",
            "process management": "Rosa is managing the discussion by providing clear and detailed explanations of the study's methodology and results."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, but that's where the opportunity is. Yeah, after reviewing all the studies, you know, your study and there is one smaller scale and that's about it. It's like the, you know, the field where there is the less human data, that's where the opportunity is. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the existing discussion about the current state of research.",
            "identify gap": "The speaker identifies a gap in human data in the field.",
            "supportive response": "The speaker's comment is supportive of further research in the area."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Well, there was a study published I think this or last week from China that is one patient, one adult patient. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, I mean. ",
        "annotations": {
            "None": "No relevant code strongly applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: The other was also like a couple of patients. I reviewed them and I was like uh when I was uh designing our study. I read all those papers. I'm like there is so few. So it's uh. ",
        "annotations": {
            "identify gap": "The speaker explicitly notes the lack of studies or patients, indicating a gap in research."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It it takes a lot of time, it takes a lot of effort, it takes a huge team. Uh but you know if you can do it, it's worth it. That's what I. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Seriously, right. Rosie, has anyone come back to medical records of people with neuropsychiatric diseases and study systematically how many how many do we see end up with the uh changes of symptoms. ",
        "annotations": {
            "ask question": "The speaker is requesting information about the existence of studies that have reviewed medical records of people with neuropsychiatric diseases to systematically assess changes in symptoms."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Depression, anxiety, whatever. Uh is there uh does it inform uh using big data including medical records early on. ",
        "annotations": {
            "ask question": "The speaker is requesting information on using big data, including medical records, to study depression, anxiety, and other conditions."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I don't know, but GI symptoms is also big signal for many of these the neurodegenerative diseases. You know that for Parkinson's like GI symptoms come years before. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the discussion about GI symptoms and their relation to neurodegenerative diseases.",
            "supportive response": "The utterance provides additional information that supports the discussion."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Exactly. ",
        "annotations": {
            "acknowledge contribution": "The speaker is acknowledging a prior statement, showing agreement without necessarily adding new content."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Rosa, I have a question for your uh for your clinical study. Under the donor samples, where did you get the donor? ",
        "annotations": {
            "ask question": "The speaker is explicitly requesting information about the source of donor samples in a clinical study, which is a clear example of asking a question."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That is that is a great question and I probably went too fast yesterday and I should have mentioned that, but I had certain amount of time. So each patient actually received microbio from two different donors because the high dose was from one donor and the maintenance dose was from another donor. And we didn't want it that way when we designed it, we wanted just one donor to keep things more systematic, but I would say we got lucky because I think the fact that we added two donors increased the diversity and our maintenance donor actually happened to be a donor that had very high diversity if you looked on the graphs. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous topic by providing more detailed information about their clinical study, including specifics about the donors used for fecal microbiota transplantation and the resulting diversity."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, and later it came in. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement or confirmation to a previous statement, showing support without adding new content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Sorry, just how are we doing on time? ",
        "annotations": {
            "code name": "process management",
            "explanation": "The speaker is inquiring about the meeting's progress in relation to time, which involves managing the meeting flow."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So I think we have 18 minutes, 18 minutes, so we can discuss maybe another three or four minutes and then look at the slides, so we can make sure that we're collect good points. What do you think Dave? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting how to use the remaining time."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Yeah, that's fine. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement or validation for a previous statement."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Good. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Yanjiao Zhou: interesting develop this microbiome based early markers, early microbiome change markers for the disease, correct? ",
        "annotations": {
            "propose new idea": "The speaker introduces the idea of developing microbiome-based early markers for the disease.",
            "ask question": "The speaker is seeking agreement or confirmation on the proposal."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, we think that those might help intervention, right? If we have an early marker. ",
        "annotations": {
            "supportive response": "The utterance expresses a positive view on the idea of using early markers for intervention.",
            "develop idea": "The utterance expands on the idea of using early markers for intervention."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It doesn't have to be microbiome, but we propose that microbiome could be a signal, maybe. ",
        "annotations": {
            "propose new idea": "The speaker suggests that the microbiome could be a signal, introducing a new perspective on its role.",
            "develop idea": "The statement builds upon existing ideas about the gut-brain connection and microbiome engineering.",
            "clarify goal": "The utterance helps to define the goal of understanding the microbiome's role as a potential signal in mental health disorders."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I'm just throwing it a thought, you guys can. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Early is everything, early is everything, because we are changing the the paradigm from precision medicine to precision health. We want to preserve health, right? Far easier than treating a disease later. ",
        "annotations": {
            "clarify goal": "The speaker defines and clarifies the objectives of moving towards precision health to preserve health, making it easier than treating diseases later."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Yanjiao Zhou: I'm just thinking about the gut microbiome. Did we think about other like microbiome, oral microbiome, other parts for the gut brain interactions or for the brain interactions. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on whether other microbiomes have been considered in the context of gut-brain interactions."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I would add it. I would add it as a point. Look look at the compartments. Where are the best sensors? Back to the issue of the sensors, right? Um do we need to interrogate a bit more and connect the dots between the the blood the the saliva and then ultimately the urine as an output, right? Should these be investigated a bit more and connected to gut microbiome composition and connect the dots with the influences of the genome and the and the the the diet and the exposome. Basic information, right? Either it might be easier for you to develop a sensor you put in the saliva, right? Or you in the urine. ",
        "annotations": {
            "ask question": "The speaker is requesting information on where the best sensors are and how to investigate the connection between bodily outputs and gut microbiome composition.",
            "propose new idea": "The speaker is suggesting a new approach to understand the connections between different bodily compartments and factors like genome, diet, and exposome."
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): I mean liquid liquid samples are way easier compared to. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Of course. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): compared to fecal samples. So there could be biomarkers that the experts can say, hey, actually, I don't know, this medium, it can be a good um, you know, place to look at, not just fecal sample, you know. ",
        "annotations": {
            "propose new idea": "The speaker suggests exploring other mediums for biomarkers, not just fecal samples.",
            "develop idea": "The speaker expands on the idea of looking for biomarkers in different mediums.",
            "encourage participation": "The speaker invites experts to consider other mediums."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Exactly, I wish we we we are not there yet. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): Really. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, but I but we know there's a lot of information in the blood, in the urine that tells me something about gut microbiome, clearly, yes. ",
        "annotations": {
            "code name": "supportive response",
            "explanation": "The speaker is expressing agreement or validation with a positive tone."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So either your electrochemistry is exquisite. ",
        "annotations": {
            "supportive response": "The speaker is expressing admiration for the capability of electrochemistry, which can be seen as a positive evaluation of a method or approach discussed."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: All of the early studies we did with the depression, anxiety, mood CNS was done with electrochemistry. It is phenomenal. Nothing compares with the exquisitive the sensitivity and the the coverage and the the depth the the of what it covers. ",
        "annotations": {
            "supportive response": "The speaker expresses a positive evaluation of electrochemistry, highlighting its sensitivity, coverage, and depth.",
            "develop idea": "The speaker elaborates on the benefits and capabilities of electrochemistry in studying depression, anxiety, mood, and CNS phenomena."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: It's a huge valuable tool. ",
        "annotations": {
            "supportive response": "Rima kaddurah daouk is expressing a positive evaluation of electrochemistry as a valuable tool for studying CNS aspects related to depression, anxiety, and mood."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation with a previous statement."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Rosie, shall we go back to minutes? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting to go back to the minutes."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We should yeah, should we go should maybe they can share his his screen and we can look at the slide, is that okay? ",
        "annotations": {
            "process management": "The speaker is suggesting an action to manage the meeting flow (sharing a screen and looking at a slide).",
            "ask question": "The speaker is asking for agreement or confirmation about the proposed action."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: You want to do that? ",
        "annotations": {
            "None": "The utterance is a question seeking confirmation or clarification on an action and does not explicitly relate to the discussion topics in a way that fits the other provided codes."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Let's do that. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and validation for another group member's contribution without adding new content."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Okay, can everybody see that? ",
        "annotations": {
            "process management": "The speaker is checking if everyone can see something, which is related to managing the meeting flow and ensuring that all participants are on the same page."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: All right, so just want to make sure I got everybody's comments well addressed here. ",
        "annotations": {
            "process management": "Dave is ensuring that all comments made by the group members are well addressed, which is a part of managing the meeting flow."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Um talked about the metabolome as a readout for not just biome changes, but it's whole body changes and how these can affect the brain. ",
        "annotations": {
            "code name": "summarize conversation",
            "explanation": "The speaker is summarizing previous discussions about the metabolome and its implications for whole-body changes and brain effects."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Um mentioned how the plasma uh even though it's not CSF or at the brain can still be an informative readout for how it affects brain. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previously discussed idea about using plasma as a readout for brain health.",
            "supportive response": "The utterance expresses agreement or validation with previous contributions by acknowledging the potential of plasma."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Um rather than bottom up, we focus a little bit more on top down signaling and how to measure. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by suggesting a focus on top-down signaling and how to measure it.",
            "clarify goal": "The speaker is contributing to defining the approach or goal of focusing on top-down signaling in the context of gut-brain interaction research."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh talked about how stress and exercise are altering the biota uh which then in turn can feedback to alter brain chemistry. ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing a part of the conversation about how stress and exercise affect the biota, which in turn can alter brain chemistry."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh looked at approaches uh to study this, potentially uh Ilian brought up bacterial receivers of top down signaling and then manipulating those pathways. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges Ilian's contribution by mentioning that Ilian brought up a point about bacterial receivers of top-down signaling."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Biosensors for uh many of these neuropeptides that we're talking about. Uh seem to be pretty well developed for the brain, but are lacking for gut. ",
        "annotations": {
            "identify gap": "The speaker identifies a gap in the development of biosensors for the gut.",
            "None": "No other code directly applies to this utterance as it does not propose a new idea, develop an existing idea, ask a question, signal expertise, or fit into other categories."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh we talked a little bit about other sites uh than just gut, um plasma, sweat, saliva for measuring some of these peptides. ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing previous conversation points about measuring peptides in various bodily fluids beyond the gut."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh we moved then onto can the biota be engineered for protective uh effects. Um kind of came to a consensus that pre clinical studies look promising, but uh we're still uh in an infancy of looking at uh clinical studies. ",
        "annotations": {
            "summarize conversation": "The utterance summarizes the discussion about engineering biota for protective effects and the current state of preclinical and clinical studies."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: And then in terms of uh when's the best time to administer some of these targeted therapies. ",
        "annotations": {
            "ask question": "The speaker is requesting information about the best time to administer targeted therapies, indicating a need for clarification or expertise from others."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Um again, still kind of need better understanding of how early can you detect these changes in the biome before over symptoms arise. ",
        "annotations": {
            "ask question": "The speaker asks a question about detecting changes in the biome.",
            "identify gap": "The speaker identifies a gap in understanding how early changes in the biome can be detected.",
            "clarify goal": "The speaker seeks clarity on the objective of detecting changes in the biome before symptoms arise."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh and this is going to require longitudinal studies. ",
        "annotations": {
            "process management": "This code applies because the speaker is discussing the necessity of longitudinal studies, which relates to planning and managing the research process."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: And pre clinical wise, there's really only a few studies right now looking at how these manipulations of the gut are actually having effect on brain chemistry. ",
        "annotations": {
            "identify gap": "The speaker highlights a gap in current research, noting that there are only a few preclinical studies examining how manipulations of the gut affect brain chemistry."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So uh we also agreed that early intervention would be great if we can find signals that help early intervention. ",
        "annotations": {
            "code name": "summarize conversation",
            "explanation": "The utterance summarizes a previously discussed point about early intervention."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: For plasma, I would put blood. It could be plasma serum, anything blood, right? Blood connecting the compartments. if you can change plasma to blood. ",
        "annotations": {
            "clarify goal": "The speaker is contributing to clarifying the goal by discussing relevant terminology and concepts, specifically regarding the use of terms like plasma and blood in a scientific context."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Blood informs about changes in the brain in the first part, yeah. In the first sentence. ",
        "annotations": {
            "None": "No relevant code explicitly applies to this utterance as it seems to be a minor clarification."
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): How about urine? How about urine? ",
        "annotations": {
            "ask question": "The speaker is requesting information about the feasibility of using urine.",
            "develop idea": "The speaker is exploring the potential of urine for biosensing in the context of gut-brain interactions."
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): Do you think urine is relevant? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the relevance of urine."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, important, the urine is important. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and emphasizing the importance of urine, showing support for the discussion point."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I would say, okay, blood right as an okay informative readout informs. I I would just put it as informs about brain changes. Blood blood blood metabolites or blood blood what? Blood markers or blood metabolites, uh blood metabolites inform about brain structural and functional changes or something. ",
        "annotations": {
            "develop idea": "The speaker is expanding on how blood metabolites could be used as indicators for brain changes.",
            "ask question": "The speaker asks for clarification or specificity regarding what to call certain markers or metabolites."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Behavior. I would also add other body fluids. Other body fluids such as saliva and urine could could have added value. ",
        "annotations": {
            "propose new idea": "The speaker suggests adding other body fluids like saliva and urine to the discussion.",
            "develop idea": "The speaker builds upon the previous discussion about body fluids by suggesting additional types to consider."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So uh Rima, I agree that they inform about brain changes, but it's it's a signal that it's a composite of a lot of other changes too, not just brain changes, right? ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing a nuanced view.",
            "acknowledge contribution": "The utterance acknowledges Rima's point and builds upon it.",
            "offer feedback": "The speaker provides a nuanced view as feedback on interpreting signals from the gut microbiome."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So when we take a blood sample, it's metabolism, it's brain, it's microbes, it's everything. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Everything, yeah. ",
        "annotations": {
            "acknowledge contribution": "Rima kaddurah daouk is acknowledging Rosa Krajmalnik-Brown's point about blood samples being a composite of many changes.",
            "supportive response": "The response is supportive and agrees with the previous statement."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It's a composite of like. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yes, it is, it is a dump of all organs. ",
        "annotations": {
            "Supportive response": "The utterance expresses agreement with a previous statement."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: But it informs, Rosie, the good news, it informs. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement and a positive evaluation for the information provided by blood metabolites, showing support for its potential to inform about brain changes."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I agree. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: About it informs whatever the signal is coming from, it tells me about FDG or neurodegeneration or yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: is that the probiotics that we'll be able to purchase at Whole Foods in a few years will be probiotics that came from human guts and that will be more effective because we've proven that those work. ",
        "annotations": {
            "ask question": "The utterance is phrased as a question about the future of probiotics.",
            "propose new idea": "The utterance speculates on a future scenario of probiotics being derived from human guts and being more effective."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: What you guys think? ",
        "annotations": {
            "ask question": "The speaker is explicitly requesting opinions or thoughts from others."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: clearly yes, you know. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Hopefully, hopefully we'll get there. Hopefully FDA will allow us to get there soon. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it does not propose a new idea, develop an existing idea, ask a question, signal expertise, identify a gap, acknowledge a contribution, offer feedback, summarize the conversation, express humor, encourage participation, manage process, assign a task, clarify a goal, or confirm a decision."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Aida, I the one comment to you, you are in the right field at the right time. Listen, digital medicine, right? Why should we have only a glucose monitor, really, think about it clinically, when you guys can develop an area of sensors that can tell me something about my health in real time. If a glucose monitor can keep me at bay, right? My glucose started to go up immediately. I stopped everything, I did the right diet, exercise, I'm back to normal. I keep my glucose next to me, monitor, imagine how many monitors you can develop, right? Out of the thousands of chemicals that can provide, you are in the right spot at the right time. We we have a big initiative starting on digital and yeah, digital health and ",
        "annotations": {
            "encourage participation": "Rima encourages Aida to consider the broader implications and potential of her work in biosensors and digital health.",
            "offer feedback": "Rima provides feedback on the potential for expanding the development of sensors beyond glucose monitoring to other health indicators.",
            "supportive response": "Rima's response is supportive of Aida's work and field, emphasizing its importance and potential impact on health monitoring."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Richard Wiener: I'll just jump in quickly to say I'm dropping by for the 10 minute warning, but it looks like you guys are summarizing but in any rate. Hi and goodbye. ",
        "annotations": {
            "process management": "The speaker mentions the 10-minute warning, indicating an awareness and management of the meeting's time."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Thank you and goodbye. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Richard Wiener: Bye. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We were right on time, Rima, before he jumped in. ",
        "annotations": {
            "process management": "The speaker is commenting on the timing of the discussion, indicating that they were on schedule before an interruption."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yes, thank you. You you managed this beautifully and interesting discussion, beautiful beautiful minds, beautiful amazing scientists of the future who are gonna make amazing things. Wonderful meeting you and working with you, best of luck. ",
        "annotations": {
            "supportive response": "The speaker is expressing gratitude and positive sentiments towards the discussion and the participants, which aligns with a supportive response."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Ilian, welcome to constructive feedback. So I put it on the chat. If you don't mind sending me an email with your constructive um um comments of what you think can be done better. I think. ",
        "annotations": {
            "encourage participation": "Rosa invites Iliyan to provide constructive feedback via email, encouraging his participation in improving the discussion or meeting."
        }
    },
    {
        "utterance": "Iliyan Iliev: Oh sure. I mean, it's actually amazing because it's the first study. So what I thought is like I probably didn't phrase it well, but those studies are the weakest because there is only one. So you have huge opportunity there. That's what I wanted to say. ",
        "annotations": {
            "identify gap": "Iliyan Iliev points out that there is only one study, indicating a gap in research.",
            "offer feedback": "Iliyan Iliev offers feedback by suggesting that this limitation presents a huge opportunity for further research."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: And I I added my email as well. Easier than. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Thank you Rima. It was great to come uh doing this with you. ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes another group member's input.",
            "supportive response": "Expressing agreement, validation, or positive evaluation for other group members' contributions without adding new content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: The same the same here Rosie, beautiful work, amazing, amazing work, amazing presentation. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and positive evaluation for the work presented by Rosie, indicating a supportive response."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And um and doing this moderation with you was great like it doesn't always work here with two people. I think it worked great and everyone participated which was great. Thank you all of you too. ",
        "annotations": {
            "supportive response": "The speaker expresses appreciation and positive evaluation for the group's participation and interaction.",
            "process management": "The speaker comments on the effectiveness of the moderation process."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Thank you. Thank you Rosie for leading. ",
        "annotations": {
            "acknowledge contribution": "The speaker is verbally recognizing Rosie's leadership and contribution to the meeting, expressing gratitude for her role in leading the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I think we had a great discussion. ",
        "annotations": {
            "Supportive response": "The speaker expresses a positive evaluation of the discussion that took place.",
            "None": "No additional codes apply as the utterance primarily serves to express agreement and positivity."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I think so. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement or confirmation with a previous statement."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I actually personally enjoyed this discussion better than the one I had yesterday. I'm I'm confessing with all of you guys. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: We won't tell here. ",
        "annotations": {
            "express humor": "The speaker is making a joke about keeping a secret."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Well, I think Dave, Pam and um and Ilian were in my group yesterday. So they might they might feel the same or differently, but I think this was a great discussion. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges the presence and potential opinions of Dave, Pam, and Iliyan from her previous group.",
            "supportive response": "The speaker expresses a positive view of the discussion.",
            "summarize conversation": "The speaker reflects on the current and a previous discussion."
        }
    },
    {
        "utterance": "Dave Durgan: Great. ",
        "annotations": {
            "supportive response": "The utterance 'Great. ' expresses agreement and a positive evaluation of a prior statement without adding new content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Thank you. Thank you all. ",
        "annotations": {
            "acknowledge contribution": "The speaker is verbally recognizing the input or participation of the group members."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Thank you for being the reporter. ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes another group member's input, in this case, thanking the reporter for their role."
        }
    },
    {
        "utterance": "Yanjiao Zhou: It's a lot of work, I know. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah, I did it last year, so I know. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: Thank you. Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We're pretty much done, so whenever they call us back, we're good. ",
        "annotations": {
            "process management": "The speaker is indicating the meeting is nearly done and they are waiting for further instructions, which is about managing the meeting's flow."
        }
    },
    {
        "utterance": "Andrew Feig: Uh, yeah, we have about five minutes before some of the other groups are still summarizing. So you're welcome to stay here in the small group and keep talking or we can go back to the main room, whichever. ",
        "annotations": {
            "process management": "Andrew Feig is managing the meeting flow by informing the group about the time constraint and suggesting possible actions."
        }
    },
    {
        "utterance": "Carolina Tropini: I have a question. Did you take the picture behind you? ",
        "annotations": {
            "ask question": "The speaker is requesting information about whether someone took a picture behind them."
        }
    },
    {
        "utterance": "Andrew Feig: Uh, I did. That was about uh two days ago. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: It's beautiful. ",
        "annotations": {
            "express humor": "The speaker makes a lighthearted comment about the picture.",
            "supportive response": "The utterance expresses a positive evaluation of the picture shown."
        }
    },
    {
        "utterance": "Andrew Feig: Um, that's a great horned owl who uh flew over my head uh maybe two feet of clearance. ",
        "annotations": {
            "express humor": "The speaker is making a humorous comment about a personal experience with a horned owl flying close to their head."
        }
    },
    {
        "utterance": "Carolina Tropini: That's crazy. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Andrew Feig: Um, yeah, this is uh out out uh probably about 15 miles from where I live uh near um Saro National Park West. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: Were you ready with the camera or do you just like, oh my god, it's coming towards me. ",
        "annotations": {
            "express humor": "The utterance expresses a lighthearted and humorous curiosity about someone's experience with a camera and a horned owl."
        }
    },
    {
        "utterance": "Andrew Feig: No, I was I was ready with the camera. It had been on the branch behind you uh behind me uh uh right before that and so. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: Very good. ",
        "annotations": {
            "supportive response": "Carolina Tropini is expressing agreement or validation of a previous statement."
        }
    },
    {
        "utterance": "Andrew Feig: Um, we have we have a lot of great uh birds. The bird the birding in Tucson is phenomenal. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: I know. ",
        "annotations": {
            "acknowledge contribution": "The speaker is acknowledging a previous statement or contribution from another group member."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So, you know, it's funny that you mentioned birds Andrew because I've been having a hard time sleeping the last week because there's a lot of birds on a tree on a tree right next to my house. Like I I I I got earplugs because they've been waking me up like at 3:00 a.m. the birds. ",
        "annotations": {
            "confirm decision": "No"
        }
    },
    {
        "utterance": "Andrew Feig: You know. And I just told my husband, maybe this will be an advantage of getting hot here. Maybe they'll leave once it gets hot because it's been really bothering my sleep as much as I love birds. We have a problem with the woodpeckers who get a little confused and they go after the some of the aluminum of the uh the drainage off the roof and they go ping ping ping ping ping ping. ",
        "annotations": {
            "express humor": "The speaker makes a joke about the potential advantage of hot weather in relation to birds disturbing their sleep."
        }
    },
    {
        "utterance": "Carolina Tropini: That's so weird that it happens there too. ",
        "annotations": {
            "Supportive response": "Carolina Tropini is expressing agreement and validation of Andrew's experience by sharing a similar personal anecdote."
        }
    },
    {
        "utterance": "Carolina Tropini: Yeah, that it's it's a huge problem right here too. Uh this woodpecker just going crazy on the um on the rain uh collecting um. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and sharing a similar experience, showing support for the previous speaker's comment."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Is there another dialog next you know about brain access or that's it because it was two years. ",
        "annotations": {
            "process management": "The speaker is managing the discussion flow by inquiring about future dialogs on a specific topic."
        }
    },
    {
        "utterance": "Andrew Feig: We run three years. So yes, there. So we have one more we have one more year. Thankfully, hopeful, hopefully in person. In person, exactly. ",
        "annotations": {
            "process management": "The speaker is discussing the timeline and continuation of a project or study, indicating management of the project's process."
        }
    },
    {
        "utterance": "Andrew Feig: So uh uh so yeah, so we will uh we will have a third year um and then uh you know for for folks that uh who have junior colleagues at the at their institutions obviously, we're running six different dialogs every year on different topics. And so there are opportunities for your colleagues who have different experimental interests to engage. So we have one that overlaps a little bit with this one in that uh the advanced advancing bioimaging or neuroimaging is uh a thread in that. Um, and then we have a new one starting in October on the molecular basis of cognition. Um, uh looking at the pathways that lead to memory formation and memory loss uh trying to get not just to get away from the circuit level which has been well studied, but down to the molecular level of of some of what drives circuit formation etc. So uh ",
        "annotations": {
            "process management": "The speaker is discussing the future plans and organization of the dialogs, including the continuation for a third year and new topics, which involves managing the structure and activities of the group."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's great. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation for a previous statement."
        }
    },
    {
        "utterance": "Andrew Feig: Okay, I think we're going to probably need to rejoin the main room. I'm going to send out that message right now, so I'll see you there. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by instructing the group to rejoin the main room and informing them he will send out a message."
        }
    }
]